Klas Hatje

9PUBLICATIONS
70CO-AUTHORS
Molecular targetsTumour immunologyBiological adaptationRespiratory diseasesAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 12, 2026
Tobemstomig, a Novel Bispecific Antibody, Preferentially Blocks PD-1 and LAG-3 on CD8 TILs to Expand Stem-like T Cells for Sustained Tumor Control.

|Apr 07, 2026
A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1-LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma.

Elena Garralda, Christoph Markert, Victor Moreno

|Jul 08, 2024
Actomyosin organelle functions of SPIRE actin nucleators precede animal evolution.

Martin Kollmar, Tobias Welz, Aishwarya Ravi

|Apr 08, 2024
Single-cell RNA-sequencing of virus-specific cellular immune responses in chronic hepatitis B patients.

Klas Hatje, Tony Kam-Thong, Nicolas Giroud

|Dec 15, 2023
Transcriptional profiling upon T cell stimulation reveals down-regulation of inflammatory pathways in T and B cells in SLE versus Sjögren's syndrome.

Gino Kwon, Annika Wiedemann, Lisa M Steinheuer

|Nov 01, 2022
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors.

Marina Natoli, Klas Hatje, Pratiksha Gulati

Pageof 2

Frequent Collaborators

2 joint publications

Tamara Hüsser

2 joint publications

Emilio Yangüez

2 joint publications

Christian Klein

2 joint publications

Henry Kao